Linear Diagnostics Limited logo — Linear Diagnostics utilises Linear Dichroism as a platform t...

Linear Diagnostics Limited

Linear Diagnostics utilises Linear Dichroism as a platform to develop point of care tests for infectious diseases.

Founded 2011 United Kingdom Birmingham, United Kingdom 6 employees Grant Total: $3.10M Biotechnology, Health Care

General Information

Company Name Linear Diagnostics Limited
Founded Year 2011
Location United Kingdom Birmingham, United Kingdom
Founders / Decision Makers
Team member
Employees 6
Industries Biotechnology, Health Care
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Linear Diagnostics Limited. To contact Linear Diagnostics Limited, visit lineardiagnostics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Linear Diagnostics Limited compare?

A PDF of Linear Diagnostics Limited and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Linear Diagnostics Limited soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Linear Diagnostics Limited

Linear Diagnostics Limited (LDL) is a United Kingdom based biotechnology and healthcare startup founded in 2011. Utilizing Linear Dichroism as a platform, LDL develops point-of-care tests for infectious diseases. The company's technology offers a novel approach to molecular diagnostics, enabling a wide range of tests to be conducted using a simple optical system. This innovative method provides several advantages over the current state of the art, allowing for the rapid detection of multiple targets with a single reagent. LDL's solution has applications across various high-value sectors, including health, food, defense, and security. LDL has forged strategic partnerships with end users such as clinical microbiology, food producers, and defense medicine, demonstrating the broad applicability of its technology. The company recently received a grant investment on 08 June 2023 from the National Institute for Health Research, a notable achievement that underscores the recognition and support for the innovative diagnostic solutions being developed by Linear Diagnostics Limited.

Business keywords: point of care tests, infectious diseases, molecular diagnostics, optical system, rapid detection, clinical microbiology, food producers, defence medicine, linear dichroism, diagnostics company, novel technology, health sector, food sector, defence and security sector

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant Undisclosed 1
National Institute for Health Research
08 Jun 2023
Venture Round £800.00K 5
UK Innovation & Science Seed Fund, Future Planet Capital +3
24 Feb 2021
Venture Round £2.00M 2
Future Planet Capital, Midlands Engine Investment Fund
08 Nov 2019
Seed Round £300.00K 2
UK Innovation & Science Seed Fund, Future Planet Capital
24 May 2017

Linear Diagnostics Limited Alternatives & Competitors

View All Alternatives
Linear Diagnostics Limited vs

Smart testing platform for rapid and accurate testing of diseases and various health condition in hu...

2-10 employees
Biotechnology, Health Care
Linear Diagnostics Limited vs
GeneCapture, Inc.
GeneCapture, Inc. United States

Reinventing Pathogen Detection

Grant
25 employees
Biotechnology, Health Care
Linear Diagnostics Limited vs

Microbiology in minutes™

36 employees
Biotechnology, Health Care

FAQ About Linear Diagnostics Limited

Linear Diagnostics utilises Linear Dichroism as a platform to develop point of care tests for infectious diseases.
Linear Diagnostics Limited was founded in 2011.
Linear Diagnostics Limited is headquartered in Birmingham, United Kingdom.
Linear Diagnostics Limited operates in Biotechnology and Health Care. Its work centres on point of care tests, infectious diseases, molecular diagnostics and optical system.
Linear Diagnostics Limited has approximately 6 employees.
Linear Diagnostics Limited has completed 4 funding rounds, raising a total of $3.10M. The latest funding stage is Grant.
Top alternatives and competitors to Linear Diagnostics Limited include Droplite, GeneCapture, Inc., Qvella Corporation, Mobidiag, A Hologic Company, Biocartis. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Linear Diagnostics Limited and Droplite are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Linear Diagnostics Limited, https://bouncewatch.com/company/linear-diagnostics-limited, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes